FDA.reportPublic FDA data

Application 208969

Type
NDA
Sponsor
AMPHASTAR PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001REXTOVYNALOXONE HYDROCHLORIDESPRAY, METERED;NASAL4MG/SPRAYYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74681SUPPL 2023-07-03
74667SUPPL 2023-06-30
74007ORIG 2023-04-17
73709ORIG 2023-03-08
73708ORIG 2023-03-08